Trimegavog 1 Tablet SR

Product Introduction

Trimegavog 1 Tablet SR belongs to a class of medicines known as oral anti-diabetic drugs. It is a triple-combination medicine used to manage Type 2 diabetes mellitus in adults, particularly when blood sugar levels are not adequately controlled by diet, exercise, or a single/dual medicine regimen.

The medicine combines three effective agents — Glimepiride, Metformin, and Voglibose — that work together to control blood sugar levels through different mechanisms. It helps the body make better use of insulin, reduces sugar production in the liver, slows the absorption of glucose from food, and promotes stable blood glucose levels throughout the day.

Trimegavog 1 Tablet SR should be taken with or immediately before meals to reduce the risk of low blood sugar and gastrointestinal side effects. Your doctor will determine the correct dose based on your blood sugar levels, response to treatment, and other medical conditions. It is important to take it at the same time each day to maintain steady blood levels and achieve maximum benefit.

Continue taking this medicine even if you feel well, as stopping it abruptly can cause a rise in blood sugar, leading to long-term complications such as nerve damage, kidney disease, vision loss, and cardiovascular problems. Along with medication, maintaining a healthy diet, regular physical activity, and weight control are crucial parts of diabetes management.

Uses of Trimegavog Tablet SR

Treatment of Type 2 Diabetes Mellitus (non-insulin-dependent diabetes)

Improved blood sugar control when monotherapy or dual therapy is insufficient

Reduction of diabetes-related complications, including nerve, kidney, and heart damage

Benefits of Trimegavog Tablet SR

In Type 2 Diabetes Mellitus:
Trimegavog 1 Tablet SR provides comprehensive blood sugar control through three complementary actions. It:

Stimulates the pancreas to release more insulin (via glimepiride)

Reduces sugar production by the liver and enhances insulin sensitivity (via metformin)

Delays carbohydrate absorption from the intestine to prevent sudden sugar spikes after meals (via voglibose)

By effectively lowering post-meal and fasting blood glucose levels, Trimegavog helps prevent long-term diabetes complications like neuropathy, nephropathy, retinopathy, and cardiovascular events. With regular use and lifestyle modification, patients can maintain stable blood sugar levels and improve overall metabolic health.

Side Effects of Trimegavog Tablet SR

Most side effects are mild and temporary. They usually disappear as your body adjusts to the medicine. However, consult your doctor if they persist or become bothersome.

Common side effects include:

Nausea or vomiting

Diarrhea

Abdominal pain or bloating

Loss of appetite

Hypoglycemia (low blood glucose level)

Flatulence (gas)

Other possible side effects:

Taste changes

Headache or dizziness

Fatigue

Swelling (edema)

Blurred vision

Bone fractures (rare)

Upper respiratory tract infection

To prevent low blood sugar, always take the medicine with meals and avoid skipping them. Keep a fast-acting carbohydrate source (like glucose tablets, candy, or fruit juice) handy to quickly manage symptoms of hypoglycemia (sweating, trembling, confusion, or hunger).

How to Use Trimegavog Tablet SR

Take this medicine in the dose and duration prescribed by your doctor.

Swallow the tablet whole with water — do not chew, crush, or break it.

It is best taken with or immediately before meals.

Take it at the same time every day to maintain consistent blood sugar control.

Do not stop taking the medicine suddenly without your doctor’s advice.

How Trimegavog Tablet SR Works

Trimegavog 1 Tablet SR is a combination of three anti-diabetic medicines, each with a distinct mechanism:

Glimepiride (Sulfonylurea):
Stimulates the pancreas to release more insulin, which helps lower blood glucose levels.

Metformin (Biguanide):
Decreases glucose production in the liver, delays glucose absorption from the intestine, and increases insulin sensitivity in body tissues.

Voglibose (Alpha-glucosidase inhibitor):
Delays the digestion and absorption of carbohydrates in the intestine, preventing sudden post-meal spikes in blood sugar levels.

Together, these actions help achieve effective and balanced blood sugar control throughout the day.

Safety Advice

Alcohol
🚫 Unsafe — Consuming alcohol can increase the risk of severe low blood sugar (hypoglycemia) and lactic acidosis. Avoid alcohol while taking Trimegavog.

Pregnancy
⚠️ Consult your doctor — Limited human data; may be unsafe during pregnancy. Your doctor will weigh potential risks and benefits before prescribing.

Breastfeeding
⚠️ Consult your doctor — Trimegavog may pass into breast milk and harm the baby. Avoid use unless clearly needed.

Driving
⚠️ Caution — Low or high blood sugar can cause dizziness, blurred vision, or confusion. Avoid driving if you experience these symptoms.

Kidney
🚫 Unsafe in severe kidney disease — Should be avoided. Regular monitoring of kidney function is recommended.

Liver
⚠️ Use with caution — Dose adjustment may be required in patients with liver impairment. Not recommended in severe liver disease.

Precautions and Warnings

Do not skip meals while taking this medicine.

Avoid excessive alcohol consumption.

Inform your doctor about all other medications you are taking, especially those affecting blood sugar.

Regularly monitor your blood glucose levels, liver function, and kidney function.

Maintain a healthy lifestyle — diet and exercise are essential for maximum benefit.

Not recommended for patients with type 1 diabetes mellitus or diabetic ketoacidosis.

Storage Instructions

Store below 30°C, in a cool, dry place away from sunlight.

Keep the container tightly closed after use.

Keep out of reach of children.